DecisionRx utilizes pharmacogenomic insights to optimize medication therapy for individual patients, significantly reducing the incidence of ineffective prescriptions. By minimizing medication failures, the platform lowers overall healthcare costs for payers and enhances patient health outcomes.
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many patients receive prescriptions that are ineffective due to genetic variations, leading to increased healthcare costs and adverse health outcomes. A significant percentage of prescriptions are ineffective or unsafe, and a large portion of healthcare costs are attributed to medication failures.
Solution
DecisionRx leverages pharmacogenomic data to optimize medication therapy for individual patients, reducing the likelihood of ineffective prescriptions. The platform empowers pharmacists to deliver personalized medication insights at scale, operating within a value-based care model. By minimizing medication failures, DecisionRx aims to lower overall healthcare costs for payers while simultaneously improving patient health outcomes. The solution provides prescribers with the necessary information to make informed decisions, ensuring patients receive the most effective medications based on their genetic profile.
Target Audience
The primary target audience includes healthcare payers and pharmacists seeking to reduce medication failures and improve patient outcomes through personalized medication therapy.
Features
- Pharmacogenomic analysis to predict individual patient response to medications.
- Personalized medication recommendations based on genetic insights.
- Scalable platform for pharmacists to deliver medication insights.
- Integration with existing pharmacy workflows.
- Reporting and analytics to track medication effectiveness and cost savings.